タンパク質フォスファタゼ2A-B56α複合体は,神経芽細胞腫におけるN-Myc分解を調節する
Brian D Tran1, Irene Peris2, Ethan Wurman2
1Department of Pharmacology, University of Michigan, Ann Arbor, Michigan, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.
The Journal of biological chemistry
|February 18, 2026
まとめ
研究者らは,PP2Aを再活性化することで,神経芽細胞腫におけるN-Mycタンパク質を減少させ,MYCNの腫瘍性シグナリングをターゲットにすることで,高リスクの神経芽細胞腫に対する新しい治療戦略を提供することを発見しました.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- バイオケミストリー バイオケミストリー
背景:
- 高リスクの神経芽細胞腫は,致命的な小児がんです.
- MYCN増幅は,腫瘍の進行と治療抵抗を促します.
- N-Mycは,神経芽細胞腫における挑戦的な治療標的である.
研究 の 目的:
- N-Mycタンパク質の安定性を調節するPP2A-B56αの役割を調査する.
- 神経芽細胞腫におけるPP2A再活性化の治療の可能性を評価する.
主な方法:
- PP2Aを標的とする小分子DT-061.1.でニューロブラストーマ細胞系を治療する.
- N-Mycタンパク質のレベル,細胞の生存能力,コロニー形成の評価.
- ニューロブラストーマの異種移植モデルを用いたインビボ研究.
主要な成果:
- PP2Aの再活性化により,神経芽細胞のN-Mycタンパク質発現が著しく低下しました.
- DT-061の治療は,N-Mycのプロテアソマル分解と細胞活性の低下につながった.
- DT-061治療を受けた異種移植モデルでは,腫瘍の成長が抑制されました.
結論:
- PP2A-B56α調節は,ニューロブラストーマにおけるMYCN腫瘍性シグナリングを効果的に標的とする.
- PP2Aを再活性化することは,高リスクの神経芽細胞腫に対する有望な治療戦略です.
関連する概念動画
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Negative Regulator Molecules
38.6K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
PI3K/mTOR/AKT Signaling Pathway
5.8K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.8K
Anaphase Promoting Complex
3.5K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.5K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
Protein Kinases and Phosphatases
15.3K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.3K


